The immunogenetic architecture of autoimmune disease

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 3, 2012, Pages

  Goris, An ^a   Liston, Adrian ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN; REVIEW;

AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HLA ANTIGENS; HUMANS; MODELS, GENETIC;

EID: 84862682781     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a007260     Document Type: Article

References (110)

1. Almeida AR, Legrand N, Papiernik M, Freitas AA. 2002. Homeostasis of peripheral CD4{thorn} T cells: IL-2R a and IL-2 shape a population of regulatory cells that controls CD4{thorn} T cell numbers. J Immunol 169: 4850-4860.
2. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, et al. 2011. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252.
3. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, et al. 2009. Genome-wide association study and metaanalysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703-707.
4. Barton NH, Keightley PD. 2002. Understanding quantitative genetic variation. Nat Rev Genet 3: 11-21.
5. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associatedwith rheumatoid arthritis. Am J Hum Genet 75: 330-337.
6. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21.
7. Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M. 2008. Natural selection on genes that underlie human disease susceptibility. Curr Biol 18: 883-889.
8. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: 337-338.
9. Braley-Mullen H, Sharp GC, Medling B, Tang H. 1999. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun 12: 157-165.
10. Brand O, Gough S, Heward J. 2005. HLA, CTLA-4 and PTPN22: The shared genetic master-key to autoimmunity? Expert Rev Mol Med 7: 1-15.
11. Broux B, Hellings N, Venken K, Rummens JL, Hensen K, Van Wijmeersch B, Stinissen P. 2010. Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor a gene influences the frequency of recent thymic emigrants. Genes Immun 11: 326-333.
12. Casto AM, Feldman MW. 2011. Genome-wide association study SNPs in the human genome diversity project populations: Does selection affect unlinked SNPs with shared trait associations? PLoS Genet 7: e1001266.
13. Clayton DG. 2009. Prediction and interaction in complex disease genetics: Experience in type 1 diabetes. PLoS Genet 5: e1000540.
14. Cooper GS, Miller FW, Pandey JP. 1999. The role of genetic factors in autoimmune disease: Implications for environmental research. Environ Health Perspect 107 (Suppl 5): 693-700.
15. Cooper GS, Bynum ML, Somers EC. 2009. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33: 197-207.
16. Corona E, Dudley JT, Butte AJ. 2010. Extreme evolutionary disparities seen in positive selection across seven complex diseases. PLoS One 5: e12236.
17. Cortes A, Brown MA. 2011. Promise and pitfalls of the Immunochip. Arthritis Res Ther 13: 101.
18. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon KC, Aubin C, Bauer D, Heubach JF, Sandbrink R, et al. 2009. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurol 8: 1111-1119.
19. Dendrou CA, Plagnol V, Fung E, Yang JH, Downes K, Cooper JD, Nutland S, Coleman G, Himsworth M, Hardy M, et al. 2009. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet 41: 1011-1015.
20. D'Netto MJ, Ward H, Morrison KM, Ramagopalan SV, Dyment DA, DeLuca GC, Handunnetthi L, Sadovnick AD, Ebers GC. 2009. Risk alleles for multiple sclerosis in multiplex families. Neurology 72: 1984-1988.
21. De Stefano N, Cocco E, Lai M, Battaglini M, Spissu A, Marchi P, Floris G, Mortilla M, Stromillo ML, Paolillo A, et al. 2006. Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. AnnNeurol 59: 634-639.
22. DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, Chang H, Caspi RR, Fong L, Anderson MS. 2006. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 203: 2727-2735.
23. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
24. Eaton WW, Pedersen MG, Atladottir HO, Gregory PE, Rose NR, Mortensen PB. 2010. The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol Res 47: 228-231.
25. Faas S, Trucco M. 1994. The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest 17: 477-495.
26. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD. 2008. Defining the role of theMHCin autoimmunity: A reviewand pooled analysis. PLoS Genet 4: e1000024.
27. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
28. Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4{thorn}CD25{thorn} regulatory T cells. Nat Immunol 4: 330-336.
29. Forabosco P, Bouzigon E, Ng MY, Hermanowski J, Fisher SA, Criswell LA, Lewis CM. 2009. Meta-analysis of genomewide linkage studies across autoimmune diseases. Eur J Hum Genet 17: 236-243.
30. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, et al. 2010. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-1125.
31. Fraser HI, Dendrou CA, Healy B, Rainbow DB, Howlett S, Smink LJ, Gregory S, Steward CA, Todd JA, Peterson LB, et al. 2010. Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene. J Immunol 184: 5075-5084.
32. Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, Oksenberg JR. 2011. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 69: 65-74.
33. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, et al. 2007. Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39: 1083-1091.
34. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G, Helgadottir H, Steinthorsdottir V, Stefansson H, et al. 2009. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41: 342- 347.
35. Guo SW. 1998. Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet 63: 252-258.
36. Haghighi S, Andersen O, Rosengren L, Bergstrom T, Wahlstrom J, Nilsson S. 2000. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J Neurol 247: 616-622.
37. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci 106: 9362-9367.
38. Hirschhorn JN, Gajdos ZK. 2011. Genome-wide association studies: Results from the first few years and potential implications for clinical medicine. Annu Rev Med 62: 11-24.
39. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
40. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599- 603.
41. Ioannidis JP, Thomas G, Daly MJ. 2009. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 10: 318-329.
42. Janssens AC, van Duijn CM. 2008. Genome-based prediction of common diseases: Advances and prospects. Hum Mol Genet 17: R166-R173.
43. Jones JL, Phuah CL, Cox AL, Thompson SA, Ban M, Shawcross J, Walton A, Sawcer SJ, Compston A, Coles AJ. 2009. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H). J Clin Invest 119: 2052-2061.
44. Khattri R, Cox T, Yasayko SA, Ramsdell F. 2003. An essential role for Scurfin in CD4{thorn}CD25{thorn} T regulatory cells. Nat Immunol 4: 337-342.
45. Kim JM, Rasmussen JP, Rudensky AY. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197.
46. Kraft P, Hunter DJ. 2009. Genetic risk prediction-Are we there yet? New Engl J Med 360: 1701-1703.
47. Kraft P, Wacholder S, Cornelis MC, Hu FB, Hayes RB, Thomas G, Hoover R, Hunter DJ, Chanock S. 2009. Beyond odds ratios-Communicating disease risk based on genetic profiles. Nat Rev Genet 10: 264-269.
48. Kramer S, Schimpl A, Hunig T. 1995. Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 182: 1769-1776.
49. Kruglyak L, Nickerson DA. 2001. Variation is the spice of life. Nat Genet 27: 234-236.
50. Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. 2005. Structure of a human autoimmune TCR bound to amyelin basic protein self-peptide and a multiple sclerosis- associated MHC class II molecule. EMBO J 24: 2968-2979.
51. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. 2003. Aire regulates negative selection of organ-specific T cells. Nat Immunol 4: 350-354.
52. Liston A, Gray DHD, Lesage S, Fletcher AL, Wilson J, Webster KE, Scott HS, Boyd RL, Peltonen L, Goodnow CC. 2004a. Gene dosage limiting role of Aire in thymic expression, clonal deletion and organ-specific autoimmunity. J Exp Med 200: 1015-1026.
53. Liston A, Lesage S, Gray DH, O'Reilly LA, Strasser A, Fahrer AM, Boyd RL, Wilson J, Baxter AG, Gallo EM, et al. 2004b. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21: 817-830.
54. Liston A, Enders A, Siggs OM. 2008. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat Rev Immunol 8: 545-558.
55. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, Charles P, Ding B, Alfredsson L, PadyukovL, et al. 2009. Specific interaction between genotype, smoking and autoimmunity to citrullinated a-enolase in the etiology of rheumatoid arthritis. Nat Genet 41: 1319-1324.
56. Makaroff L, Linterman M, Liston A. 2008. Genetic control of T cell tolerance and susceptibility to autoimmune disease. In Genetic predisposition to disease (ed. Torres S, Marin M) Nova, Hauppauge NY.
57. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al. 2009. Finding the missing heritability of complex diseases. Nature 461: 747-753.
58. Maynard J, Petersson K, Wilson DH, Adams EJ, Blondelle SE, Boulanger MJ, WilsonDB, GarciaKC. 2005. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: Insights into MHC bias and antigen specificity.Immunity 22: 81-92.
59. McDuffie M. 2000. Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse. Clin Immunol 96: 119-130.
60. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. 2007. TGF-b and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8: 1390-1397.
61. McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, Ippoliti A, Vasiliauskas E, Berel D, Derkowski C, et al. 2010. Fucosyltransferase 2 (FUT2) nonsecretor status is associated with Crohn's disease. Hum Mol Genet 19: 3468-3476.
62. Meda F, Folci M, Baccarelli A, Selmi C. 2011. The epigenetics of autoimmunity. Cell Mol Immunol 8: 226-236.
63. Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, Amininejad L, Cleynen I, Colombel JF, de Rijk P, Dewit O, et al. 2011. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 43: 43-47.
64. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, et al. 1997. Positional cloning of the APECED gene. Nat Genet 17: 393-398.
65. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcon-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA, et al. 2011. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12: 270-279.
66. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against Type 1 diabetes. Science 324: 387-389.
67. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
68. Padyukov L, Seielstad M, Ong RT, Ding B, Ronnelid J, Seddighzadeh M, Alfredsson L, Klareskog L. 2011. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 70: 259-265.
69. Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, Chatterjee N. 2010. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 42: 570-575.
70. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. 2002. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33-36.
71. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, et al. 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39: 596- 604.
72. Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science 273: 1516-1517.
73. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.
74. Sawcer S. 2008. The complex genetics of multiple sclerosis: Pitfalls and prospects. Brain 131: 3118-3131.
75. Sawcer S, Ban M, Wason J, Dudbridge F. 2010.What role for genetics in the prediction of multiple sclerosis? Ann Neurol 67: 3-10.
76. Smerdel A, Dai KZ, Lorentzen AR, Flato B, Maslinski S, Thorsby E, Forre O, Spurkland A. 2004. Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene. Genes Immun 5: 310-312.
77. Smith DJ, Lusis AJ. 2002. The allelic structure of common disease. Hum Mol Genet 11: 2455-2461.
78. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, et al. 2004.Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023.
79. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger DB, et al. 2006. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38: 617-619.
80. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, et al. 2010. Genome-wide association study metaanalysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42: 508-514.
81. Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, et al. 2010. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42: 985-990.
82. Surolia I, Pirnie SP, Chellappa V, Taylor KN, Cariappa A, Moya J, Liu H, Bell DW, Driscoll DR, Diederichs S, et al. 2010. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 466: 243-247.
83. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor b. Science 268: 1472-1476.
84. Suzuki H, Zhou YW, Kato M, Mak TW, Nakashima I. 1999. Normal regulatory a/b T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor b in vivo. J Exp Med 190: 1561-1572.
85. Taubert R, Schwendemann J, Kyewski B. 2007. Highly variable expression of tissue-restricted self-antigens in human thymus: Implications for self-tolerance and autoimmunity. Eur J Immunol 37: 838-848.
86. The Finnish-German APECEDConsortium. 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17: 399-403.
87. The International HapMap Consortium. 2003. The International HapMap Project. Nature 426: 789-796.
88. The International Multiple Sclerosis Genetics Consortium. 2005. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 77: 454-467.
89. The International Multiple Sclerosis Genetics Consortium. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. New Engl J Med 357: 851-862.
90. The International Multiple Sclerosis Genetics Consortium, Bush WS, Sawcer SJ, De Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance M, Haines JL. 2010. Evidence for polygenic susceptibility to multiple sclerosis-The shape of things to come. Am J Hum Genet 86: 621-625.
91. The International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium 2. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
92. The MHC Sequencing Consortium. 1999. Complete sequence and gene map of a human major histocompatibility complex. Nature 401: 921-923.
93. The Wellcome Trust Case Control Consortium. 2007. Genome- wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
94. The Wellcome Trust Case Control Consortium. 2010. Genome- wide association study of CNVs in 16,000 cases of eight common diseases and 3000 shared controls. Nature 464: 713-720.
95. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, et al. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39: 857-864.
96. Trowsdale J. 2011. The MHC, disease and selection. Immunol Lett 137: 1-8.
97. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
98. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15: 289-292.
99. van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE. 2007. Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. Arthritis Rheum 56: 1728-1735.
100. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, Nika K, Tautz L, Tasken K, Cucca F, et al. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37: 1317-1319.
101. Vyse TJ, Todd JA. 1996. Genetic analysis of autoimmune disease. Cell 85: 311-318.
102. Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N, Gohlke H, Wagenpfeil S, Ollert M, Ring J, et al. 2008. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 4: e1000166.
103. Weidinger S, Baurecht H, Naumann A, Novak N. 2010. Genome- wide association studies on IgE regulation: Are genetics of IgE also genetics of atopic disease? Curr Opin Allergy Clin Immunol 10: 408-417.
104. Wen L, Wong FS, Sherwin R, Mora C. 2002. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7. J Immunol 168: 3635- 3640.
105. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20.
106. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.
107. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, MiyaraM, Fehervari Z, Nomura T, Sakaguchi S. 2008. CTLA-4 control over Foxp3{thorn} regulatory T cell function. Science 322: 271-275.
108. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montgomery GW, et al. 2010. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42: 565-569.
109. Zhernakova A, van Diemen CC, Wijmenga C. 2009. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10: 43-55.
110. Ziegler AG, Nepom GT. 2010. Prediction and pathogenesis in type 1 diabetes. Immunity 32: 468-478.